AXEVIL Capital

ElevenLabs Stock

Private company — ElevenLabs is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$85.35 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 8 September 2026

Valuation: $17.33B

Source: D, February 2026 — post-money $11B

Data last updated: 22 September 2026

About ElevenLabs

British developer of AI voice synthesis and cloning, voiceover, and dubbing technology. Raised $500M in a Series D in February 2026 led by Sequoia at an $11B valuation, more than triple its January 2025 level. Annual recurring revenue reached about $500M. Exploring an IPO.

ElevenLabs makes machine speech indistinguishable from human speech and sells it as a ready-made layer for other companies' products. Founded in 2022 in London. The same model narrates an audiobook, dubs a video into 70 languages, and holds a live conversation with a bank's customer in place of an agent. Before ElevenLabs, synthesized voice always gave itself away by intonation and was used only where a live narrator could not be hired; the company's models carry pauses, emotion, and breath. Annual revenue went $25M to $90M to $330M to $500M in three and a half years. More than 2 million voice agents have been deployed, and over 33 million conversations conducted. Valued at $11B in a Series D (February 2026, $54.18 per share); roughly $781M raised.

  • Sector: Artificial Intelligence
  • Headquarters: London, United Kingdom
  • Founded: 2022

Funding rounds

DateRoundPrice / sharePost-money valuation
4 February 2026D$54.18$11B
30 January 2025C$17.47$3.3B
22 January 2024B$6.36$1.09B
1 May 2023A-1$0.64$120M
23 January 2023A-4$0.08$10M

Frequently asked questions

Can I buy ElevenLabs stock?

Not on a public exchange — ElevenLabs is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

How much is one ElevenLabs share?

A private company has no single official price. AXEVIL's consensus estimate is $85.35 per share as of 8 September 2026. Its most recent round implied a post-money valuation of $11B (February 2026).

When will ElevenLabs IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is ElevenLabs publicly traded?

No. ElevenLabs is a private company and its shares are not listed on any public exchange.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies